MedPath

武汉加成医药科技有限公司

Ownership
-
Established
2003-12-12
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Sodium Nitroprusside For Injection

Product Name
注射用硝普钠
Approval Number
国药准字H20065354
Approval Date
Aug 15, 2024
NMPA

Disodium Folinate for Injection

Product Name
注射用亚叶酸钠
Approval Number
国药准字H20090013
Approval Date
May 29, 2023
NMPA

Disodium Folinate for Injection

Product Name
注射用亚叶酸钠
Approval Number
国药准字H20090012
Approval Date
May 29, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.